Symmetry Medical, Inc. (SMA) Tops Q2 EPS by 2c, Lowers FY11 EPS and Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q2 adjusted EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $94.72 million versus the consensus estimate of $96.06 million.
Symmetry Medical, Inc. sees FY2011 EPS of $0.43-$0.57, versus prior guidance of $0.54-$0.65 and the consensus of $0.57. Symmetry Medical, Inc. sees FY2011 revenue of $354-$370 million, versus prior guidance of $363-$383 million and the consensus of $376.91 million.
Symmetry Medical, Inc. sees FY2011 EPS of $0.43-$0.57, versus prior guidance of $0.54-$0.65 and the consensus of $0.57. Symmetry Medical, Inc. sees FY2011 revenue of $354-$370 million, versus prior guidance of $363-$383 million and the consensus of $376.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InterDigital (IDCC) Tops Q3 EPS by 177c ; Offers Guidance
- Ameriprise Financial (AMP) Tops Q3 EPS by 30c
- EMCOR Group (EME) Tops Q3 EPS by 123c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
